Salvage capacity of hepatoma 3924A and action of dipyridamole

Weber, 1982, Multi-enzyme-targeted chemotherapy by acivicin and actinomycin, Advances in Enzyme Regulation, 20, 75, 10.1016/0065-2571(82)90009-7 Denton, 1982, Rapid in vivo inactivation by acivicin of CTP synthetase, carbamoyl-phosphate synthetase II, and amidophosphoribosyltransferase in hepatoma, Life Sci., 30, 1073, 10.1016/0024-3205(82)90527-6 Aoki, 1981, Carbamoyl phosphate synthetase (glutamine-hydrolyzing): Increased activity in cancer cells, Science, 212, 463, 10.1126/science.7209543 Weber, 1981, Dynamics of modulation of biochemical programs in cancer cells, Advances in Enzyme Regulation, 19, 87, 10.1016/0065-2571(81)90010-8 Weber, 1977, Enzymology of cancer cells, New England J. Med., 296, 486, 10.1056/NEJM197703032960905 Weber, 1977, Enzymology of cancer cells, New England J. Med., 296, 541, 10.1056/NEJM197703102961005 Weber, 1980, Biochemical commitment to replication in cancer cells, Advances in Enzyme Regulation, 18, 3, 10.1016/0065-2571(80)90005-9 Prajda, 1975, Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of glutamine PRPP amidotransferase (amidophosphoribosyltransferase, EC 2.4.2.14), Cancer Res., 35, 3061 Jackson, 1977, Enzymes of the purine ribonucleotide cycle in rat hepatomas and kidney tumors, Cancer Res., 37, 3057 Boritzki, 1981, Guanosine 5′-phosphate synthetase and guanosine 5′-phosphate kinase in rat hepatomas and kidney tumors, Biochim. Biophys. Acta, 658, 102, 10.1016/0005-2744(81)90253-9 Aoki, 1982, Regulatory properties and behavior of activity of carbamoyl phosphate synthetase, 257, 432 Kizaki, 1980, Increased cytidine 5′-triphosphate synthetase activity in rat and human tumors, Cancer Res., 40, 3921 Takeda, 1981, Role of ribonucleotide reductase in expression of the neoplastic program, Life Sci., 28, 1007, 10.1016/0024-3205(81)90746-3 Weber, 1978, Biochemical strategy of the genome as expressed in regulation of pyrimidine metabolism, Advances in Enzyme Regulation, 16, 3, 10.1016/0065-2571(78)90064-X Harkrader, 1980, Increase in liver and kidney deoxycytidine kinase activity linked to neoplastic transformation, Biochem. Biophys. Res. Commun., 96, 1633, 10.1016/0006-291X(80)91361-3 Natsumeda, 1983 Jackson, 1980, Purine and pyrimidine nucleotide patterns of normal, differentiating and regenerating liver and of hepatomas in rats, Cancer Res., 40, 1286 Weber, 1971, Metabolism of hepatomas of different growth rates in situ and during ischemia, Cancer Res., 31, 2177 Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 Olah, 1980, Phase and cell cycle specificity of pyrazofurin action, Cancer Res., 40, 2869 Olah, 1979, Giemsa-banding karyotype of rat hepatomas of different growth rates, Cancer Res., 39, 1708 Prajda, 1975, Malignant transformation-linked imbalance: Decreased xanthine oxidase activity in hepatomas, FEBS Letters, 59, 245, 10.1016/0014-5793(75)80385-1 Prajda, 1976, Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of xanthine oxidase (EC 1.2.3.2), Cancer Res., 36, 4639 Kumar, 1972, Guanine deaminase in rat liver and mouse liver and brain, Biochem. J., 128, 1079, 10.1042/bj1281079 Jackson, 1975, IMP dehydrogenase, an enzyme linked with proliferation and malignancy, Nature, 256, 331, 10.1038/256331a0 Aoki, 1982, In vivo inactivation of carbamoylphosphate synthetase II in rat hepatoma, Biochem. Pharmacol., 31, 927, 10.1016/0006-2952(82)90322-7 Zhen, 1982, Effect of combination of acivicin (AV) and a nucleoside transport inhibitor, dipyridamole (DP), on hepatoma 3924A cells, 664 Zhen, 1983, Effects of acivicin and dipyridamole on hepatoma 3924A cells, Cancer Res., 43 Lui, 1983, Action of dipyridamole and acivicin on hepatoma 3924A